Liver Fibrosis—From Mechanisms of Injury to Modulation of Disease
Christian Liedtke(Universitätsklinikum Aachen), Ralf Weiskirchen(Universitätsklinikum Aachen), René H. Tolba(RWTH Aachen University), Alexander Wree(Klinikum im Friedrichshain), Pavel Strnad(RWTH Aachen University), Tilman Sauerbruch(University Hospital Bonn), Yulia A. Nevzorova(Universidad Complutense de Madrid), Jonel Trebicka(Klinik für Schlafmedizin), Daniela C. Kroy(RWTH Aachen University), Jacob Nattermann(University Hospital Bonn), Ulrich Spengler(University of Bonn), Zeinab Abdullah(University Hospital Bonn), Marie‐Luise Berres, Twan Lammers(RWTH Aachen University), Jürgen Bernhagen(LMU Klinikum), Frank Tacke(Charité - Universitätsmedizin Berlin), Tom Luedde(Düsseldorf University Hospital), Henning W. Zimmermann(Sankt-Antonius-Hospital Eschweiler), Christian Trautwein(TUM Klinikum)
Cited by 38
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.5k
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
|Nature Reviews Gastroenterology & Hepatology|2011|1.4k
Tumor targeting via EPR: Strategies to enhance patient responses
|Advanced Drug Delivery Reviews|2018|1.2k